Will the FDA approve a psychedelic-assisted therapy for a mental disorder by 2027?
Salud y medicinaOne-Off2m
Manifold MarketsSin KYCDatos de resolución verificadosCalibración aceptableAviso de calidad de datosDatos de la fuente degradados
Datos del 26 oct 2026, 17:11 UTC · política pm-quality-4
Pronóstico comunitario actual
No 66.4%
No 66.4%Pronosticadores
18
Tipo de pregunta
binary
Metodología
Play-money forecasting platform
Tipo de fuente
Pronóstico
Datos de mercado
Actualizado hace 1 hora
Retrasado5 oct 24, 2:42 UTC2 ene 27, 4:59 UTC
Tendencias
Mercados Relacionados
Preguntas relacionadas para dar contexto, no una comparación de contratos equivalentes.
Will the FDA approve any psychedelic substance for medical use this year?
KalshiWill the FDA approve any psychedelic substance for medical use before 2028?
KalshiWill MDMA-assisted therapy for PTSD be approved by the FDA before 2030?
Manifold MarketsBy 2028 end, will there be AI-assisted therapy, where therapists visually explore a patient's thoughts/memories?
Manifold MarketsBy 2030, will the FDA approve any drug in combination with a checkpoint blockade therapy that substantially reduces immune escape?
Manifold MarketsWhen will the FDA approve Compass Pathways' COMP360 Psilocybin?
KalshiReglas
https://www.science.org/content/article/fda-rejected-mdma-assisted-ptsd-therapy-other-psychedelics-firms-intend-avoid-fate
- Resolves YES if any currently known psychedelic substance (as of October 4th, 2024) is FDA approved for any category of mental disorder by January 1st 2027.
- The caveat is mainly to avoid the possibility that any subsequent drug development produces a treatment for a mental disorder that is later found out to have psychedelic effects.
- Possible clarification from creator (AI generated): Market will resolve as N/A if the FDA is abolished before January 1st 2027.
